Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 43/72 ]
NYSE | Common Stock
Bausch + Lomb Corporation operates as an eye health company worldwide.
It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical.
The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products for therapeutic use, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, dry eye, and redness relief.
The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases.
The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices.
Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada.
Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jul 31, 24 | 0.18 Increased by 0.00% | 0.12 Increased by +50.00% |
| May 1, 24 | 0.07 Decreased by -30.00% | 0.07 |
| Feb 21, 24 | 0.24 Increased by +4.35% | 0.17 Increased by +41.18% |
| Nov 1, 23 | 0.22 Decreased by -29.03% | 0.18 Increased by +22.22% |
| Aug 2, 23 | 0.18 Decreased by -37.93% | 0.15 Increased by +20.00% |
| May 3, 23 | 0.10 Decreased by -33.33% | 0.14 Decreased by -28.57% |
| Feb 22, 23 | 0.23 Increased by +138.33% | 0.22 Increased by +4.55% |
| Nov 2, 22 | 0.31 | 0.23 Increased by +34.78% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 1.01 B Increased by +6.90% | -84.00 M Decreased by -460.00% | Decreased by -8.34% Decreased by -423.85% |
| Jun 30, 23 | 1.03 B Increased by +9.99% | -32.00 M Decreased by -557.14% | Decreased by -3.09% Decreased by -515.62% |
| Mar 31, 23 | 931.00 M Increased by +4.72% | -88.00 M Decreased by -540.00% | Decreased by -9.45% Decreased by -520.15% |
| Dec 31, 22 | 996.00 M Decreased by -0.50% | -1.00 M Decreased by -101.96% | Decreased by -0.10% Decreased by -101.97% |
| Sep 30, 22 | 942.00 M Decreased by -0.74% | -15.00 M Decreased by -125.00% | Decreased by -1.59% Decreased by -125.19% |
| Jun 30, 22 | 941.00 M Increased by +0.75% | 7.00 M Decreased by -84.09% | Increased by +0.74% Decreased by -84.21% |
| Mar 31, 22 | 889.00 M Increased by +0.91% | 20.00 M Decreased by -25.93% | Increased by +2.25% Decreased by -26.59% |
| Dec 31, 21 | 1.00 B Increased by +6.04% | 51.00 M Increased by +124.40% | Increased by +5.09% Increased by +123.01% |